Projects per year
Activity of the pterin- and folate-salvaging enzymes pteridine reductase I (PTR1) and dihydrofolate reductase-thymidylate synthetase (DHFR-TS) is commonly measured as a decrease in absorbance at 340 nm, corresponding to oxidation of nicotinamide adenine dinucleotide phosphate (NADPH). Although this assay has been adequate to study the biology of these enzymes, it is not amenable to support any degree of routine inhibitor assessment because its restricted linearity is incompatible with enhanced throughput microtiter plate screening. In this article, we report the development and validation of a nonenzymatically coupled screening assay in which the product of the enzymatic reaction reduces cytochrome c, causing an increase in absorbance at 550 nm. We demonstrate this assay to be robust and accurate, and we describe its utility in supporting a structure-based design, small-molecule inhibitor campaign against Trypanosoma brucei PTR1 and DHFR-TS. (C) 2009 Elsevier Inc. All rights reserved.
|Number of pages||10|
|Publication status||Published - 15 Jan 2010|
- Drug discovery
- Pteridine reductase
- Dihydrofolate reductase
- PARASITE LEISHMANIA-MAJOR
- BINDING INHIBITION CONSTANTS
- THYMIDYLATE SYNTHASE
FingerprintDive into the research topics of 'Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase'. Together they form a unique fingerprint.
- 2 Finished
Aref#d: 19815. Wellcome Trust Centre for Drug Discovery (Strategic Award)
Fairlamb, A., Ferguson, M. & Frearson, J.
1/01/08 → 31/12/12